(Q47800744)

5 February 2018

title

Pramipexole reverses Parkinson's disease-related motivational deficits in rats (English)

1 reference

5 February 2018

1 reference

Mathieu Favier

1

1 reference

5 February 2018

Theo Duran

2

1 reference

5 February 2018

Carole Carcenac

3

1 reference

5 February 2018

Guillaume Drui

4

1 reference

5 February 2018

Marc Savasta

5

1 reference

5 February 2018

Sebastien Carnicella

6

1 reference

5 February 2018

language of work or name

English

0 references

publication date

11 February 2014

1 reference

5 February 2018

published in

Movement Disorders

1 reference

5 February 2018

volume

29

1 reference

5 February 2018

issue

7

1 reference

5 February 2018

page(s)

912-920

1 reference

5 February 2018

1 reference

The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease

21 January 2018

1 reference

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

21 January 2018

1 reference

Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease.

21 January 2018

1 reference

Differential diagnosis and classification of apathy

21 January 2018

1 reference

Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom

21 January 2018

1 reference

Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits

21 January 2018

1 reference

The nosological position of apathy in clinical practice

21 January 2018

1 reference

Disconnecting force from money: effects of basal ganglia damage on incentive motivation

21 January 2018

1 reference

Non-motor symptoms in Parkinson's disease

21 January 2018

1 reference

Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.

21 January 2018

1 reference

Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?

21 January 2018

1 reference

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

21 January 2018

1 reference

Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours

21 January 2018

1 reference

Motivation, reward, and Parkinson's disease: influence of dopatherapy.

21 January 2018

1 reference

The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies

21 January 2018

1 reference

Dysthymia and apathy: diagnosis and treatment

21 January 2018

1 reference

Deep brain stimulation: from neurology to psychiatry?

21 January 2018

1 reference

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

21 January 2018

1 reference

Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment

21 January 2018

1 reference

Apathy in Parkinson's disease: diagnosis, neuropsychological correlates, pathophysiology and treatment

21 January 2018

1 reference

Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats

21 January 2018

1 reference

A review of the receptor-binding and pharmacokinetic properties of dopamine agonists

21 January 2018

1 reference

Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae

21 January 2018

1 reference

Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.

21 January 2018

1 reference

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

21 January 2018

1 reference

GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse

21 January 2018

1 reference

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

21 January 2018

1 reference

The behavioural effects of pramipexole, a novel dopamine receptor agonist

21 January 2018

1 reference

Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats

21 January 2018

1 reference

The debate over dopamine's role in reward: the case for incentive salience

21 January 2018

1 reference

Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction

21 January 2018

1 reference

Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease

21 January 2018

1 reference

The role of the basal ganglia in habit formation

21 January 2018

1 reference

Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.

21 January 2018

1 reference

Early behavioral changes after nigro-striatal system damage can serve as predictors of striatal dopamine depletion

21 January 2018

1 reference

Parkinson's disease: levodopa-induced dyskinesia and signal transduction.

21 January 2018

1 reference

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

21 January 2018

1 reference

The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders

21 January 2018

1 reference

Pramipexole upregulates dopamine receptor D₂ and D₃ expression in rat striatum.

21 January 2018

1 reference

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

21 January 2018

1 reference

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

21 January 2018

1 reference

Impulsive and compulsive behaviors in Parkinson's disease.

21 January 2018

1 reference

21 January 2018

1 reference

Reinforcing properties of Pramipexole in normal and parkinsonian rats

21 January 2018

1 reference

Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.25837

1 reference

5 February 2018

1 reference

5 February 2018